Predictive Intelligence

Predictive Analytics

AI-driven risk stratification, revenue forecasting, and patient outcome predictions

AI Insights Summary

3 patients require attention this week

Kamal Perera, Ruwan Silva, and Saman Bandara flagged for elevated risk scores

Revenue trending +8.5% month-over-month

Predicted Q1 revenue exceeds target by LKR 52,000 based on current trajectory

Predicted no-show rate: 4.3% (below clinic average)

Clinic average is 7.8% -- AI scheduling interventions reducing no-shows

Risk Stratification Matrix

High (>60%)Moderate (30-60%)Low (<30%)
PatientNo-Show RiskReadmission RiskDeterioration RiskComplianceTrend
KP

Kamal Perera

45y · Type 2 Diabetes, Hypertension

No-Show12%
Readmission35%
Deterioration42%
68
%
Declining
NF

Nimali Fernando

32y · Asthma

No-Show5%
Readmission18%
Deterioration22%
88
%
Stable
RS

Ruwan Silva

58y · Chronic Lower Back Pain, Osteoarthritis

No-Show22%
Readmission28%
Deterioration38%
62
%
Stable
AJ

Anoma Jayawardena

27y · Iron Deficiency Anemia

No-Show8%
Readmission10%
Deterioration12%
92
%
Improving
SB

Saman Bandara

63y · COPD, Atrial Fibrillation

No-Show30%
Readmission55%
Deterioration68%
45
%
Declining

Revenue Forecast

ActualPredictedFuture
080K160K240K320K400KSepOctNovDecJanFebMarAprRevenue (LKR)

Patient Risk Scores

42
Kamal PereraModerate

MODERATE RISK — Increased monitoring needed. Consider closer follow-up schedule.

22
Nimali FernandoLow

MODERATE RISK — Continue current management. Reassess at next scheduled visit.

38
Ruwan SilvaModerate

MODERATE RISK — Continue current management. Reassess at next scheduled visit.

12
Anoma JayawardenaLow

LOW RISK — Patient progressing well. Standard follow-up schedule appropriate.

68
Saman BandaraHigh

HIGH RISK — Immediate intervention recommended. Schedule priority follow-up within 48 hours.

36%

Avg Risk Score

1

High-Risk Patients

71%

Avg Compliance

94.2%

AI Confidence